Literature DB >> 9872475

Immunoglobulin variable region sequences of human monoclonal anti-DNA antibodies.

A Rahman1, D S Latchman, D A Isenberg.   

Abstract

OBJECTIVE: Anti-DNA antibodies are believed to be important in the pathogenesis of systemic lupus erythematosus (SLE). Antibodies that bind specifically and with high affinity to dsDNA are most closely involved in tissue damage. Analysis of the sequences of the variable regions of human monoclonal anti-DNA antibodies is useful in defining the structural features that give rise to these binding properties. This article systematically reviews the evidence derived from such sequences.
METHOD: Previous reviews of this subject have been hampered by incomplete knowledge of the human immunoglobulin variable region repertoire. In this article, the original sequence data from reports of over 50 human monoclonal antibodies (mAb) are reinterpreted by alignment to the most similar alleles of the most similar germline genes. This allows accurate estimation of the site and nature of somatic mutations.
RESULTS: Human IgG monoclonal anti-DNA antibodies generally carry more mutations than IgM. In many cases these have been selected by an antigen-driven process. In many of the more specific, higher affinity dsDNA binders, there is an accumulation of basic residues in the complementarity determining regions. However, many exceptions to this rule exist, particularly among IgM mAb.
CONCLUSIONS: Unlike murine anti-DNA antibodies, these human mAb show little evidence for preferential use of particular V(H), V(K) and V(lambda) genes or families to encode antibodies of this specificity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872475     DOI: 10.1016/s0049-0172(98)80031-0

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  7 in total

1.  The role of somatic mutation in determining the affinity of anti-DNA antibodies.

Authors:  M Behrendt; L J Partridge; B Griffiths; M Goodfield; M Snaith; N J Lindsey
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 2.  B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.

Authors:  Angela Lee Foreman; Judy Van de Water; Marie-Lise Gougeon; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2007-01-12       Impact factor: 9.754

3.  The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.

Authors:  Ian Giles; Nancy Lambrianides; David Latchman; Pojen Chen; Reginald Chukwuocha; David Isenberg; Anisur Rahman
Journal:  Arthritis Res Ther       Date:  2004-11-16       Impact factor: 5.156

4.  Functional consequences of complementarity-determining region deactivation in a multifunctional anti-nucleic acid antibody.

Authors:  Jiyeon Lee; Hye-Jin Kim; Jooho Roh; Youngsil Seo; Minjae Kim; Hye-Ryeong Jun; Chuong D Pham; Myung-Hee Kwon
Journal:  J Biol Chem       Date:  2013-10-23       Impact factor: 5.157

5.  Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis.

Authors:  Geraldine Cambridge; Rita A Moura; Tania Santos; Akif A Khawaja; Joaquim Polido-Pereira; Helena Canhão; Maria J Leandro; João E Fonseca
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

6.  Impact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire.

Authors:  Chenchen Zhang; Andrea Björkman; Kaiye Cai; Guilin Liu; Chunlin Wang; Yin Li; Huihua Xia; Lijun Sun; Karsten Kristiansen; Jun Wang; Jian Han; Lennart Hammarström; Qiang Pan-Hammarström
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

7.  Structure-function analysis and molecular modeling of DNase catalytic antibodies.

Authors:  Haggag S Zein; Jaime A Teixeira da Silva; Kazutaka Miyatake
Journal:  Immunol Lett       Date:  2010-01-25       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.